Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etanercept and Narrow-Band UVB in Psoriasis Vulgaris
NCT00640393Phase 4Completed
- Sponsor
- Innovaderm Research
- Start
- Apr 2008
- Primary completion
- Feb 2010
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 4 trial of etanercept in Psoriasis vulgaris (PV), sponsored by Innovaderm Research. Started Apr 2008; status: completed.
02
Drugs
etanercept
03
Conditions
Psoriasis vulgaris (PV)
Beyond the preview
Go deeper on NCT00640393.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00640393.